Endpoints News 生物医药· Drew Armstrong·· 2026-10-19精选AI 评分80
德国默克(Merck KGaA)同意以13亿美元收购Silence Therapeutics及其siRNA管线
Merck KGaA to buy Silence Therapeutics and its siRNA pipeline for $1.3B
AI 导读
德国默克(Merck KGaA)同意以13亿美元收购英国药物开发商Silence Therapeutics及其siRNA管线,以拓展在罕见病和专科疾病领域的研发工作。
推荐理由
原文明示收购标的、金额与战略意图,可据此理解跨国药企以siRNA技术布局罕见病和专科疾病领域的资本动向。
正文 · 原文
Germany’s Merck KGaA agreed to buy UK drug developer Silence Therapeutics for $1.3 billion, building out its work in rare and specialty diseases using genetic …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news